Silence Therapeutics PLC
(OTCPK:SLNCF)
$
8.37
-0.58 (-6.48%)
Market Cap: 1.17 Bil
Enterprise Value: 1.06 Bil
PE Ratio: 0
PB Ratio: 7.41
GF Score: 45/100 Silence Therapeutics PLC (SLNCF) Transcripts
- Full Year 2021 Silence Therapeutics PLC Earnings Call TranscriptMar 17, 2022$5Earnings
- Silence Therapeutics PLC Corporate Call TranscriptOct 21, 2021
- Silence Therapeutics PLC at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Half Year 2021 Silence Therapeutics PLC Earnings Call TranscriptAug 12, 2021$8.3Earnings
- Silence Therapeutics PLC at Needham Healthcare Conference (Virtual) TranscriptApr 14, 2021
- Full Year 2020 Silence Therapeutics PLC Earnings Call TranscriptMar 30, 2021$7.8Earnings
- Silence Therapeutics PLC at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Silence Therapeutics PLC at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Silence Therapeutics PLC at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Half Year 2020 Silence Therapeutics PLC Earnings Call TranscriptSep 14, 2020$6.14Earnings
- Full Year 2019 Silence Therapeutics PLC Earnings Call TranscriptApr 14, 2020$5.95 (+4.02%)Earnings
- Silence Therapeutics PLC Collaboration With AstraZeneca and R&D Update Call TranscriptMar 25, 2020
- Silence Therapeutics PLC and Mallinckrodt Plc Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases TranscriptJul 18, 2019
- 1